Am Puls der Zeit
im Bereich der Forschung
Patente
- Schwabe, K., Keck, C. M., Rimpler C. (2008)
Lipid Nanoparticles for the Enhancement of the dermal action of solid particles,
European Patent Application No. 08 019 306.3, 4 Nov. 2008. - Schwabe K.; Dr. Rimpler GmbH (2012),
Aqueous dispersion having a content of lipid nanoparticles, process for production thereof and use thereof,
European Patent Application No. 07580, 17Okt. 2012.,
-Ceraparts® a novel lipidnanoparticle carier system for topical application-
Wirkstoffträgersysteme
- Schwabe, K., Müller, R. H., Hommoss, A.,
Nanorepair Q10 – First dermal product on the market based on nanostructured lipid carrier (NLC) technology, proceeding in the 5th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology,
Geneva, March 27-30, 2006 - Müller, R. H., Hommoss, A., Schwabe, K., Rimpler, M.,
Dermal coenzyme Q10 formulations based on nanostructured lipid carrier (NLC), abstract in the Annual Meeting of the American Association of Pharmaceutical Scientists (AAPS),
San Antonio, USA, No. M1269, October 29 – November 2, 2006 - Müller, R. H., Hommoss, A., Schwabe, K.,
Lipid Nanoparticles (SLN, NLC) – Present state of development for dermal delivery, abstract in the European Workshop on Particulate Systems (EWPS),
Geneva, March 23-25, 2006 - Müller, R. H., Petersen, R., Hommoss, A., Schwabe, K.,
A new dimension in cosmetic products by nanostructured lipid carriers (NLC) technology,
Euro Cosmetics, 2007, 3, 32-37 - Müller, R. H., Hommoss, A., Schwabe, K., Lipophiler
Wirkstofftransport durch NLC-Technologie,
Euro Cosmetics, 2005, 11/12, 2-5 - Schwabe, K.,
NLC (Nanostructured Lipid Carrier) more than just a cariersystem,
Eurocosmetics, 2010, 6, 9-28 - Padeike, J., Schwabe, K., Müller, R. H.,
Influence of nanostructured lipid carriers (NLC) on the physical properties of the Cutanova Nanorepair Q10 cream and the in vivo skin hydration effect,
Int. J. of Pharmaceutics, 2010 (8), 386, 1-2, 166-173 - Schwabe K., Rimpler C.,
“Frei von- Produkte“ – Moderne Emulsionen und wie Sie wirken.
Kosmetik und Pflege, 2012 (3), 32-33
Wirkstoffforschung
- Obaidat, W. Schwabe, K. Müller, R. H., Keck, C. M.,
Preservation of nanostructured lipid carriers (NLC)
Eur. J. Pharm. Biopharm., 2010 (9), 76 (1), 56-57 - Schwabe K., Niggemann O. Hommoss A.,
Ceraparts® – In vivo efficacy via physical skin care,
SÖFW-Journal, 20012 (10), 138, 10-17 - Schwabe K.,
Spannende Zeiten – Trends in der Wirkstoffforschung,
Medical Beauty – Das dermo-kosmetische Fachmagazin, 2013 (1), 9 - Schwabe K., Niggemann O.,
Active ingredients for physical skin care,
COSSMA, 2012, 5, 10-12 - Schwabe K.,
ECM Complex- Der Haut Architekt,
Medical Beauty – Das dermo-kosmetische Fachmagazin, 2013 (4), 4-5 - Wolf G., Schwabe M., Wolf M., Schwabe K.,
Lactobacillus Rye Flour Ferment/Filtrate – Nachhaltige probiotische Wirkstoffkomplexe für die moderne Hautpflege,
SÖFW-Journal, 20014 (3), 140, 2-9 - Schwabe M., Rey L.,
Woresana®: un actif biotechnologique pour des cosmétiques de pointe / Biotechnological active for advanced skincare,
Expression Cosmétique, 2014 (12), 261-265 - Schwabe K.,
Logistik vom Feinsten – Ausgeklügelte Trägersysteme sorgen dafür, dass Wirkstoffe in Pflegeprodukten genau in jene Hautbereiche gelangen wo sie Alterungsprozesse effektiv verzögern können.,
medical BEAUTY FORUM 2015 (1), 12-17
Bitterstoff Forschung
- Wölfle U. * ID, Haarhaus B., Seiwerth J., Cawelius A., Schwabe K., Quirin K-W, Schempp C. M.,
The Herbal Bitter Drug Gentiana lutea Modulates Lipid Synthesis in Human Keratinocytes In Vitro and In Vivo,
Int. J. Mol. Sci. 2017, 18, 1814; doi:10.3390/ijms18081814 - Weber N, Schwabe K, Schempp CM, Wölfle U.,
Effect of a botanical cleansing lotion on skin sebum and erythema of the face: A randomized controlled blinded half-side comparison.
J Cosmet Dermatol. 2018 Jul 18. doi: 10.1111/jocd.12680. - Wölfle U, Haarhaus B, Seiwerth J, Cawelius A, Schwabe K, Quirin KW, Schempp CM.,
The Herbal Bitter Drug Gentiana lutea Modulates Lipid Synthesis in Human Keratinocytes In Vitro and In Vivo.
Int J Mol Sci. 2017 Aug 22;18(8). pii: E1814. doi: 10.3390/ijms18081814. - Seiwerth J, Tasiopoulou G, Hoffmann J, Wölfle U, Schwabe K, Quirin KW, Schempp CM.
Anti-Inflammatory Effect of a Novel Topical Herbal Composition (VEL-091604) Consisting of Gentian Root, Licorice Root and Willow Bark Extract.
Planta Med. 2019 Jan 28. doi: 10.1055/a-0835-6806. [Epub ahead of print] - Weber N, Schwabe K,Biehler K, Haarhaus B, Quirin KW, Frank U, Schempp CM, Wölfle U.
Hop Extract Acts as an Antioxidant with Antimicrobial Effects against Propionibacterium Acnes and Staphylococcus Aureus.
2019 Jan 9;24(2). pii: E223. doi: 10.3390/molecules24020223. - Hurth Z., Faber ML., Gendrisch F., Holzer M.ID, Haarhaus B., Cawelius A,
Schwabe K., Schempp C. M., Wölfle U. *ID,
The Anti-Inflammatory Effect of Humulus lupulus Extract In Vivo Depends on the Galenic System of theTopical Formulation,
Pharmaceuticals 2022, 15, 350., https://doi.org/10.3390/ph15030350
Spezielle Applikationen
- Keck, C. M., Schwabe K..
Silver-Nanolipid complex for application to atopic dermatitis skin rheological characterization, in vivo efficiency & theory of action,
J. Biomed. Nanotechnol., 2009 (8), 5 (4), 428-436 - Schwabe, K. and Keck C. M., (2009).
Silver-nanolipid formulation for skin care in atopic dermatitis.
5th German-Polish Symposium „New Challenges for Pharmaceutical Sciences“, 15 May, Poznan/Poland - Schwabe, K. and Keck, C. M.,
Combination of Nanostructured Lipid Carriers (NLC) and Microsilver – novel concept for atopic dermatitis,
2nd Pharmaceutical Siences Fair & Exhibition (PharmSciFair), 8-12 June, Nice/France, 2009 - Schwabe, K., Keck, C.M.,
Microsilver NLC complex for the treatment of atopic eczema, Controlled Release
Society German Chapter Annual Meeting, 2009 Halle/Saale, March 19-20. - Schwabe K. and Keck C. M. (2009).
Microsilver-NLC complexes – a novel formulation principle for the treatment of atopic eczema,
Controlled Release Society German Chapter Annual Meeting 2009, March 19-20, Halle/Germany, O14. - Keck C.M., Müller R.H., Schwabe K.,
Anantaworasakul P., Patel M., Okonogi S., Singh K. K., Roessner D., Scherres R., Silver-nanolipid-complex- A new concept for the treatment of atopic dermatitis,
Int. J. of Pharmaceutics, 2, 462 (2014), 44– 51
Technologie
- Hommoss, A., Schwabe, K., Müller, R. H.,
Nanostructured lipid carrier (NLC) in cosmetic dermal formulations,
abstract in the 7th European Workshop on Particulate Systems (EWPS), Berlin, May 30-31, 2008 - Hommoss, A., Schwabe, K., Müller, R. H.,
Nanostructured lipid carrier (NLC) in cosmetic dermal formulations,
abstract in the 7th European Workshop on Particulate Systems (EWPS), Berlin, May 30-31, 2008 - Schwabe, K., Keck C.M.,
Industrial scaling up of nanostructured lipid carrier (NLC) production using reverse flow chamber technology.
Annual Meeting of the German Pharmaceutical Society (DPhG), Jena/Germany, 2009 - Schwabe K., Niggemann O., Hommoss A.,Lingen K.,
Ceraparts® – A new dimension of Skin Care,
SEPAWA Congress, Fulda/ Germany 2012 - Hurth Z., Faber ML., Gendrisch F., Holzer M.ID, Haarhaus B., Cawelius A,
Schwabe K., Schempp C. M., Wölfle U. *ID,
The Anti-Inflammatory Effect of Humulus lupulus Extract In Vivo Depends on the Galenic System of the Topical Formulation,
Pharmaceuticals 2022, 15, 350 - Schempp C. M., Schwabe K., Kurz B., Niebel D., Youn Becker-Weimann S.,
Aspekte der Nachhaltigkeit in der topischen Therapie- Aspects of sustainability of topical therapy,
Die Dermatology 2023, 74, 21-26
Offizieller Forschungs-Partner des Propharm Netzwerkes
Ein Unternehmen der TU-Braunschweig.
